| END患者(n = 121) | 无END的患者(n = 449) | P值 |
年龄(岁) | 70.9 ± 11.6 | 67.8 ± 15.2 | 0.015 |
男性(n,%) | 69 (57.0) | 244 (54.3) | 0.624 |
高血压(n,%) | 89 (73.6) | 325 (72.4) | 0.798 |
糖尿病(n,%) | 58 (47.9) | 157 (34.9) | 0.008 |
入院时NIHSS评分 | 11.3 ± 4.2 | 11.5 ± 4.4 | 0.651 |
高脂血症(n,%) | 87 (71.9) | 321 (71.5) | 0.998 |
院内治疗(n,%) |
|
|
|
溶栓 | 2 (1.7) | 9 (2.0) | 0.998 |
降血压药物 | 96 (79.3) | 365 (81.3) | 0.435 |
降血糖药物 | 60 (49.6) | 183 (40.8) | 0.089 |
他汀类药物 | 119 (98.3) | 442 (98.4) | 0.996 |
阿司匹林 | 71 (57.9) | 215 (48.1) | 0.032 |
阿司匹林加氯吡格雷 | 50 (42.1) | 234 (51.9) | 0.032 |
CYP2C19*2 |
|
|
|
GG | 52 (42.9) | 261 (58.1) | 0.004 |
AG + AA | 69 (57.0) | 188 (41.9) | 0.004 |
入院时血小板聚集率(%) |
|
|
|
AA诱导的血小板聚集率 | 90.8 ± 12.8 | 85.5 ± 18.7 | <0.001 |
ADP诱导的血小板聚集率 | 89.7 ± 13.4 | 84.6 ± 15.5 | <0.001 |
入院时血小板–白细胞聚集(%) |
|
|
|
白细胞 | 25.8 ± 5.2 | 22.5 ± 4.8 | <0.001 |
中性粒细胞 | 23.6 ± 5.7 | 21.3 ± 4.3 | <0.001 |
单核细胞 | 32.2 ± 6.8 | 27.7 ± 7.1 | <0.001 |
淋巴细胞 | 25.4 ± 5.9 | 23.2 ± 5.2 | <0.001 |